Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells

BMC Complement Altern Med. 2012 Jan 16:12:6. doi: 10.1186/1472-6882-12-6.

Abstract

Background: Oral candidiasis is a common fungal disease mainly caused by Candida albicans. The aim of this study was to investigate the effects of A-type cranberry proanthocyanidins (AC-PACs) on pathogenic properties of C. albicans as well as on the inflammatory response of oral epithelial cells induced by this oral pathogen.

Methods: Microplate dilution assays were performed to determine the effect of AC-PACs on C. albicans growth as well as biofilm formation stained with crystal violet. Adhesion of FITC-labeled C. albicans to oral epithelial cells and to acrylic resin disks was monitored by fluorometry. The effects of AC-PACs on C. albicans-induced cytokine secretion, nuclear factor-kappa B (NF-κB) p65 activation and kinase phosphorylation in oral epithelial cells were determined by immunological assays.

Results: Although AC-PACs did not affect growth of C. albicans, it prevented biofilm formation and reduced adherence of C. albicans to oral epithelial cells and saliva-coated acrylic resin discs. In addition, AC-PACs significantly decreased the secretion of IL-8 and IL-6 by oral epithelial cells stimulated with C. albicans. This anti-inflammatory effect was associated with reduced activation of NF-κB p65 and phosphorylation of specific signal intracellular kinases.

Conclusion: AC-PACs by affecting the adherence properties of C. albicans and attenuating the inflammatory response induced by this pathogen represent potential novel therapeutic agents for the prevention/treatment of oral candidiasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Biofilms / drug effects
  • Candida albicans / drug effects*
  • Candida albicans / pathogenicity
  • Candidiasis, Oral / drug therapy*
  • Candidiasis, Oral / metabolism
  • Candidiasis, Oral / microbiology
  • Cell Adhesion / drug effects
  • Epithelial Cells / drug effects
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Interleukins / metabolism*
  • Mouth Mucosa / cytology
  • Mouth Mucosa / drug effects*
  • Mouth Mucosa / microbiology
  • NF-kappa B / metabolism
  • Phosphorylation
  • Phosphotransferases / metabolism
  • Phytotherapy
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Proanthocyanidins / pharmacology*
  • Proanthocyanidins / therapeutic use
  • Saliva
  • Vaccinium macrocarpon / chemistry*

Substances

  • Anti-Inflammatory Agents
  • Interleukin-6
  • Interleukin-8
  • Interleukins
  • NF-kappa B
  • Plant Extracts
  • Proanthocyanidins
  • Phosphotransferases